Simplify Propel Opportunities ETF (SURI) Alternatives
Simplify Propel Opportunities ETF (SURI) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with SURI. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.
Cheapest Alternatives to SURI
SURI charges 2.51% annually. Among ETFs in the Health & Biotech Equities category, these options have the lowest expense ratios among SURI alternatives.
| Symbol | Name | Expense Ratio | Inception | |
|---|---|---|---|---|
| Fidelity MSCI Health Care Index ETF | 0.08% | Oct 21, 2013 | SURI vs FHLC | |
| State Street Health Care Select Sector SPDR ETF | 0.08% | Dec 16, 1998 | SURI vs XLV | |
| Vanguard Health Care ETF | 0.10% | Jan 26, 2004 | SURI vs VHT | |
| Invesco S&P SmallCap Health Care ETF | 0.29% | Apr 7, 2010 | SURI vs PSCH | |
| SPDR S&P Pharmaceuticals ETF | 0.35% | Jun 19, 2006 | SURI vs XPH |
Best Risk-Adjusted Alternatives to SURI
Among ETFs in the Health & Biotech Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.
| Symbol | Name | Risk / Return Rank | Inception | |
|---|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | 97 | Dec 16, 2014 | SURI vs BBC | |
| ALPS Medical Breakthroughs ETF | 95 | Dec 31, 2014 | SURI vs SBIO | |
| SPDR S&P Biotech ETF | 92 | Feb 6, 2006 | SURI vs XBI | |
| Tema Oncology ETF | 90 | Aug 14, 2023 | SURI vs CANC | |
| F/m Emerald Life Sciences Innovation ETF | 86 | Oct 30, 2024 | SURI vs LFSC |
Top Performing SURI Alternatives (YTD)
SURI alternatives from the Health & Biotech Equities category, sorted by year-to-date return.
| Symbol | Name | YTD Return | Inception | |
|---|---|---|---|---|
| iShares Genomics Immunology and Healthcare ETF Gen... | 10.92% | Jun 11, 2019 | SURI vs IDNA | |
| Virtus LifeSci Biotech Clinical Trials ETF | 7.95% | Dec 16, 2014 | SURI vs BBC | |
| Tema Oncology ETF | 5.69% | Aug 14, 2023 | SURI vs CANC | |
| SPDR S&P Biotech ETF | 4.76% | Feb 6, 2006 | SURI vs XBI | |
| First Trust Nasdaq Pharmaceuticals ETF | 4.48% | Sep 20, 2016 | SURI vs FTXH |
Lowest Volatility Alternatives to SURI
SURI alternatives from the Health & Biotech Equities category, sorted by annualized volatility over the past year.
| Symbol | Name | Volatility 1Y | Inception | |
|---|---|---|---|---|
| Principal Healthcare Innovators Index ETF | 0.00% | Aug 19, 2016 | SURI vs BTEC | |
| Loncar Cancer Immunotherapy ETF | 0.00% | Oct 13, 2015 | SURI vs CNCR | |
| Amplify Treatments, Testing and Advancements ETF | 0.00% | Jun 17, 2020 | SURI vs GERM | |
| Horizon Kinetics SPAC Active ETF | 8.60% | Jun 29, 2007 | SURI vs SPAQ | |
| Global X Aging Population ETF | 15.94% | May 9, 2016 | SURI vs AGNG |
Lowest Drawdown Alternatives to SURI
SURI alternatives from the Health & Biotech Equities category, sorted by maximum drawdown over the past year.
| Symbol | Name | Max Drawdown 1Y | Inception | |
|---|---|---|---|---|
| Amplify Treatments, Testing and Advancements ETF | 0.00% | Jun 17, 2020 | SURI vs GERM | |
| Horizon Kinetics SPAC Active ETF | -5.30% | Jun 29, 2007 | SURI vs SPAQ | |
| Jpmorgan Healthcare Leaders ETF | -9.68% | Nov 1, 2023 | SURI vs JDOC | |
| VanEck Vectors Pharmaceutical ETF | -10.02% | Dec 20, 2011 | SURI vs PPH | |
| Global X Aging Population ETF | -10.16% | May 9, 2016 | SURI vs AGNG |
Other ETFs from Simplify
Most popular Simplify ETFs on PortfoliosLab, across asset classes.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | Inception | |
|---|---|---|---|---|---|---|
| Simplify Volatility Premium ETF | Volatility, Actively Managed | 17 | -7.92% | May 12, 2021 | SURI vs SVOL | |
| Simplify Managed Futures Strategy ETF | Systematic Trend | 25 | 12.39% | Mar 7, 2022 | SURI vs CTA | |
| Simplify Hedged Equity ETF | Options Trading | 82 | -1.40% | Nov 1, 2021 | SURI vs HEQT | |
| Simplify Bitcoin Strategy PLUS Income ETF | Cryptocurrency | 5 | -32.88% | Sep 29, 2022 | SURI vs MAXI | |
| Simplify High Yield PLUS Credit Hedge ETF | High Yield Bonds | 14 | -2.19% | Feb 14, 2022 | SURI vs CDX | |
| Simplify Interest Rate Hedge ETF | Hedge Fund, Actively Managed | 16 | -2.90% | May 10, 2021 | SURI vs PFIX | |
| Simplify Stable Income ETF | Government Bonds | 27 | 0.97% | Oct 27, 2022 | SURI vs BUCK | |
| Simplify Enhanced Income ETF | Derivative Income, Dividend, Actively Managed | 23 | -2.89% | Oct 27, 2022 | SURI vs HIGH | |
| Simplify Aggregate Bond ETF | Intermediate Core Bond | 26 | 0.08% | Feb 14, 2022 | SURI vs AGGH | |
| Simplify MBS ETF | Government Bonds | 76 | -0.43% | Nov 6, 2023 | SURI vs MTBA |
Often Compared With SURI
What investors most often compare with SURI, based on PortfoliosLab usage data.
Compare SURI with Any Fund or Stock
Compare SURI with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.